Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mesalazine and/or Lactobacillus Casei in Maintaining Remission of Symptomatic Uncomplicated Diverticular Disease of the Colon: a Double-blind, Double-dummy, Placebo-controlled Study
Brief Summary: This is a multi-centre, randomised, double blind, double-dummy, parallel groups, placebo-controlled trial was conducted in a population of patients suffering from symptomatic uncomplicated diverticular disease in order to investigate which is the best treatment in preventing relapses of the disease.

Patients were randomly divided in double-blind fashion in one of the following groups:

Group A. Active mesalazine 800 mg, 2 tablets/day for 10 days/month plus Lactobacillus casei placebo, 1 sachet/day for 10 days/month;

Group B. Active Lactobacillus casei, 1 sachet/day for 10 days/month plus mesalazine 800 placebo, 2 tablets/day for 10 days/month;

Group C. Active mesalazine 800 ng, 2 tablets/day plus Active Lactobacillus casei, 1 sachet/day for 10 days/month;

Group D. Mesalazine 800 mg placebo, 2 tablets/day and Lactobacillus casei placebo, 1 sachet/day for 10 days/month.

The main objective was to assess the safety and the efficacy of mesalazine and/or Lactobacillus casei in maintaining remission of symptomatic uncomplicated diverticular disease


Options:
A: Arm Label: Antibiotic; Type: ACTIVE_COMPARATOR; Interventions: Drug: Antibiotic | Arm Label: No antibiotic; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Antibiotic; Assigned to Arm(s): Antibiotic
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Other: Dietary Advice, Drug: Antibiotic for Diverticulitis | Arm Label: Mesalamine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalamine, Other: Dietary Advice, Drug: Antibiotic for Diverticulitis | Arm Label: Mesalamine & Probiotic; Type: ACTIVE_COMPARATOR; Interventions: Drug: Probiotic, Other: Dietary Advice, Drug: Antibiotic for Diverticulitis | Intervention Type: DRUG; Name: Mesalamine; Assigned to Arm(s): Mesalamine | Intervention Type: DRUG; Name: Probiotic; Assigned to Arm(s): Mesalamine & Probiotic | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: OTHER; Name: Dietary Advice; Assigned to Arm(s): Mesalamine, Mesalamine & Probiotic, Placebo | Intervention Type: DRUG; Name: Antibiotic for Diverticulitis; Assigned to Arm(s): Mesalamine, Mesalamine & Probiotic, Placebo
C: Arm Label: mesalamine; Type: ACTIVE_COMPARATOR; Interventions: Drug: mesalamine | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: mesalamine; Assigned to Arm(s): mesalamine | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: Mesalazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalazine 800 mg | Arm Label: Lactobacillus casei; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lactobacillus casei | Arm Label: Mesalazine plus Lactobacillus casei; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalazine plus Lactobacillus casei | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Mesalazine placebo plus Lactobacillus casei placebo | Intervention Type: DRUG; Name: Mesalazine plus Lactobacillus casei; Assigned to Arm(s): Mesalazine plus Lactobacillus casei | Intervention Type: DRUG; Name: Mesalazine placebo plus Lactobacillus casei placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Mesalazine 800 mg; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Lactobacillus casei; Assigned to Arm(s): Lactobacillus casei

Answer: D